The overall long term objective of this project is to create a high resolution database reflecting the global gene expression profile of lymph node negative (LNN) breast tumors. Our hypothesis is that the analysis of global patterns of gene expression of LNN breast cancers will allow us to identify subsets of tumors with differential clinical outcome. We will specifically compare the gene expression profile of primary T1 and T2N0,0 breast tumors which after follow up demonstrated recurrence post-surgery versus tumors that did not relapse. To this end, we will use the Serial Analysis of Gene Expression (SAGE) methodology which generates quantitative and qualitative sequence information of all the transcripts being expressed by the cancerous cells. These studies constitute a critical component of this Program Project since the results to be obtained will create the foundation for the identification and selection of a reduced set of """"""""signature genes"""""""" which will be further analyzed prospectively in large tumor sets by the methodology described in Project 2. S.
Aim 1 : To generate a high resolution global gene expression database of LNN breast carcinomas. These baseline databases will be primarily used for cross-validation with Rapid Analysis of Gene Expression (RAGE) methodology (Project 2), a targeted gene expression methodology, which will concentrate in low abundant transcripts and cancer related genes. The main objective of this SAGE-RAGE complementary approach is to select the primary set of 'signature genes'. S.
Aim 2 : To develop, adapt and validate a LCM based methodology for SAGE analysis. This approach will allow use to analyze separately the major cellular compartments of normal and tumor breast. We will generate """"""""Master Transcription Profiles"""""""" for a) normal breast epithelial; b) normal breast stroma; c) LNN breast tumor epithelium; d) LNN breast tumor stroma. S.
Aim 3 : To expand the SAGE databases to larger numbers of LNN breast carcinomas with and without recurrence, in order to obtain a highly comprehensive picture on the transcriptome of lymph node negative breast carcinomas and to identify low copy number transcripts of relevance. The gene expression datasets will fr used for the adaptation and evaluation of statistical methodologies (existing and novel) by Project 3. These initial datasets will also be used for testing of Web based data analysis and visualization tools to be developed by Core B. s.
Aim 4 : To identify and clone representative novel candidate target genes whose expression vary significantly between the different groups of lymph node negative breast carcinomas.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19CA084978-02
Application #
6585974
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-04-16
Project End
2003-03-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
$158,272
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Abel, E L; Boulware, S; Fields, T et al. (2013) Sulforaphane induces phase II detoxication enzymes in mouse skin and prevents mutagenesis induced by a mustard gas analog. Toxicol Appl Pharmacol 266:439-42
Abba, M C; Lacunza, E; Nunez, M I et al. (2009) Rhomboid domain containing 2 (RHBDD2): a novel cancer-related gene over-expressed in breast cancer. Biochim Biophys Acta 1792:988-97
Abba, Martín C; Hu, Yuhui; Levy, Carla C et al. (2009) Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model. Cancer Prev Res (Phila) 2:175-84
Wang, Aijin; Arantes, Stacey; Yan, Leqin et al. (2008) The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis. BMC Cancer 8:268
Abba, Martin C; Sun, Hongxia; Hawkins, Kathleen A et al. (2007) Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 5:881-90
Abba, Martin C; Fabris, Victoria T; Hu, Yuhui et al. (2007) Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34. Cancer Res 67:4104-12
Abba, Martin C; Nunez, Maria I; Colussi, Andrea G et al. (2006) GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells. Breast Cancer Res 8:R64
Spyres, Lea; Gaddis, Sally; Bedford, Ella et al. (2005) Quantitative high-throughput measurement of gene expression with sub-zeptomole sensitivity by capillary electrophoresis. Anal Biochem 345:284-95
Abba, Martin C; Hu, Yuhui; Sun, Hongxia et al. (2005) Gene expression signature of estrogen receptor alpha status in breast cancer. BMC Genomics 6:37
Baggerly, Keith A; Deng, Li; Morris, Jeffrey S et al. (2004) Overdispersed logistic regression for SAGE: modelling multiple groups and covariates. BMC Bioinformatics 5:144

Showing the most recent 10 out of 15 publications